Literature DB >> 19538958

Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.

Federica Collino1, Alberto Revelli, Marco Massobrio, Dionyssios Katsaros, Michel Schmitt-Ney, Giovanni Camussi, Benedetta Bussolati.   

Abstract

Vasculogenesis, or recruitment of progenitors able to differentiate into endothelial-like cells, may provide an important contribution to neovessel formation in tumors. However, the factors involved in the vasculogenic process and in particular the role of the epithelial-mesenchymal transition of tumor cells have not yet been investigated. We found a CD14(+)/KDR(+) angiogenic monocyte population in undifferentiated ovarian tumors, significantly increased in the corresponding tumor metastasis. In vitro, monocyte differentiation into CD14(+)/KDR(+) cells was induced by conditioned media from the primary ovarian tumor cells expressing a mesenchymal phenotype. In contrast, the ovarian tumor cell line SKOV3 expressing an epithelial phenotype was unable to stimulate the differentiation of monocytes into CD14(+)/KDR(+) cells. When an epithelial-mesenchymal transition was induced in SKOV3, they acquired this differentiative ability. Moreover, after mesenchymal transition pleiotrophin expression by SKOV3 was increased and conversely its blockade significantly reduced monocyte differentiation. The obtained CD14(+)/KDR(+) cell population showed the expression of endothelial markers, increased the formation of capillary-like structures by endothelial cells and promoted the migration of ovarian tumor cells in vitro. In conclusion, we showed that the epithelial-mesenchymal transition of ovarian tumor cells induced differentiation of monocytes into the pro-angiogenic CD14(+)/KDR(+) population and thus it may provide a tumor microenvironment that favours vasculogenesis and metastatization of the ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538958     DOI: 10.1016/j.yexcr.2009.06.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Clinical research device for ovarian cancer detection by optical spectroscopy in the ultraviolet C-visible.

Authors:  Ronie George; Archana Chandrasekaran; Molly A Brewer; Kenneth D Hatch; Urs Utzinger
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

Review 2.  One microenvironment does not fit all: heterogeneity beyond cancer cells.

Authors:  Ik Sun Kim; Xiang H-F Zhang
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

3.  Twist1 induces CCL2 and recruits macrophages to promote angiogenesis.

Authors:  Janine M Low-Marchelli; Veronica C Ardi; Edward A Vizcarra; Nico van Rooijen; James P Quigley; Jing Yang
Journal:  Cancer Res       Date:  2013-01-15       Impact factor: 12.701

4.  DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Authors:  Nilotpal Roy; Prashant V Bommi; Uppoor G Bhat; Shaumick Bhattacharjee; Indira Elangovan; Jing Li; Krushna C Patra; Dragana Kopanja; Adam Blunier; Richard Benya; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

5.  Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.

Authors:  Kamisha T Woolery; Patricia A Kruk
Journal:  Obstet Gynecol Int       Date:  2011-06-26

6.  Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.

Authors:  Stefania Bruno; Cristina Grange; Federica Collino; Maria Chiara Deregibus; Vincenzo Cantaluppi; Luigi Biancone; Ciro Tetta; Giovanni Camussi
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

7.  Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.

Authors:  Rafael Soares Lindoso; Federica Collino; Giovanni Camussi
Journal:  Oncotarget       Date:  2015-04-10

8.  Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition.

Authors:  Yi-Cun Zhong; Ting Zhang; Wen Di; Wei-Ping Li
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

9.  VEGF and pleiotrophin modulate the immune profile of breast cancer.

Authors:  Kristi D Lynn; Christina L Roland; Rolf A Brekken
Journal:  Cancers (Basel)       Date:  2010-05-26       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.